Lemon Medical GmbH

Lemon Medical GmbH specializes in developing and manufacturing diagnostic devices aimed at pulmonary function testing, providing essential tools for healthcare professionals in assessing respiratory health. Founded in 2009 and headquartered in Hammelburg, Germany, Lemon Medical GmbH focuses on producing diagnostic devices for medical professionals. The company underwent a significant transition when it was acquired by MGC Diagnostics Corporation on November 22, 2021. CEO Michaela Albert oversees the company, which has completed one investment deal to date.

Lemon Medical GmbH specializes in the development and manufacturing of diagnostic devices for pulmonary function testing, essential tools for medical professionals evaluating respiratory health. Their core offerings include devices with multi-user compatible software that integrates with practice computers and hospital information systems. These devices prioritize patient safety and comfort while delivering precise and reliable test results. The product range also includes accessories such as virus and bacterial filters, nose clips, and mouthpieces, catering to healthcare providers globally across Europe, North America, and Asia.

Lemon Medical GmbH generates revenue primarily through direct sales of its diagnostic devices and accessories to hospitals, clinics, and medical practices. The company engages in B2B transactions, partnering with healthcare institutions to provide specialized pulmonary function testing equipment. The revenue structure is bolstered by recurring orders for consumables like filters and mouthpieces, fostering ongoing client relationships. Specific pricing plans for products are not disclosed, but the company emphasizes maintaining high-quality standards and regulatory compliance, positioning its products competitively in the medical supply market.

The acquisition by MGC Diagnostics Corporation will enhance in-house manufacturing capabilities and broaden product offerings in Europe. Lemon Medical GmbH is expected to focus on expanding its market reach, although specific new products or regional targets have yet to be detailed. The recent acquisition will support these initiatives, strengthening the company's presence in the diagnostic sector and ensuring robust growth in the coming years.